Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients

References

• Glinka A, Wu W, Delius H, Monaghan AP, Blumenstock C, Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 1998;391:357–362. doi:10.1038/348489450748
   PubMed Web of Science ®Google Scholar
• Krupnik VE, Sharp JD, Jiang C, et al. Functional and structural diversity of the human Dickkopf gene family. Gene. 1999;238:301–313. doi:10.1016/S0378-1119(99)00365-010570958
   PubMed Web of Science ®Google Scholar
• Fedi P, Bafico A, Soria AN, et al. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem. 1999;274:19465–19472. doi:10.1074/jbc.274.27.1946510383463
   PubMed Web of Science ®Google Scholar
• Li J, Gong W, Li X, et al. Recent progress of Wnt pathway inhibitor Dickkopf-1 in liver cancer. J Nanosci Nanotechnol. 2018;18(8):5192‐5206. doi:10.1166/jnn.2018.14636
   Web of Science ®Google Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781‐810. doi:10.1146/annurev.cellbio.20.010403.113126
   PubMed Web of Science ®Google Scholar
• Katoh M. WNT/PCP signaling pathway and human cancer (review). Oncol Rep. 2005;14(6):1583‐1588.
   Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26. doi:10.1016/j.devcel.2009.06.01619619488
   PubMed Web of Science ®Google Scholar
• Mao B, Wu W, Li Y, et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature. 2001;411(6835):321‐325. doi:10.1038/35077108
   Web of Science ®Google Scholar
• Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol. 2001;3(7):683‐686. doi:10.1038/35083081
   PubMed Web of Science ®Google Scholar
• Lai SL, Chien AJ, Moon RT. Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. Cell Res. 2009;19:532–545. doi:10.1038/cr.2009.4119365405
   PubMed Web of Science ®Google Scholar
• van Amerongen R, Nusse R. Towards an integrated view of Wnt signaling in development. Development. 2009;136:3205–3214. doi:10.1242/dev.03391019736321
   PubMed Web of Science ®Google Scholar
• Abrahamsson AE, Geron I, Gotlib J, et al. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci U S A. 2009;106:3925–3929. doi:10.1073/pnas.090018910619237556
   PubMed Web of Science ®Google Scholar
• Valencia A, Román-Gómez J, Cervera J, et al. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia. 2009;23:1658–1666. doi:10.1038/leu.2009.8619387464
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Cordeu L, Agirre X, et al. Epigenetic regulation of Wnt-signaling pathway in acute lymphoblastic leukemia. Blood. 2007;109:3462–3469. doi:10.1182/blood-2006-09-04704317148581
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi:10.1038/nature1125222810696
   PubMed Web of Science ®Google Scholar
• Qin WX, Zhang HT, Yu YJ, et al. Uses of DKK-1 protein in diagnosis of cancer. Patent, WO/2007/104181 A1. 2007.
   Google Scholar
• Yu YJ, Wan XZ, Yu B, et al. Expression of Dickkopf (Dkk1) in liver cancer and in multiple human cancer cell lines. Zhongliu. 2006;26:1109–1112.
   Google Scholar
• Yu B, Yang X, Xu Y, et al. Elevated expression of Dkk1 is associated with cytoplasmic/nuclear β-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol. 2009;50:948–957. doi:10.1016/j.jhep.2008.11.02019303159
   PubMed Web of Science ®Google Scholar
• Sato N, Yamabuki T, Takano A, et al. Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy. Cancer Res. 2010;70:5326–5336. doi:10.1158/0008-5472.CAN-09-387920551066
   PubMed Web of Science ®Google Scholar
• Tung EK, Mak CK, Fatima S, et al. Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. Liver Int. 2011;31:1494–1504. doi:10.1111/j.1478-3231.2011.02597.x21955977
   PubMed Web of Science ®Google Scholar
• Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol. 1999;155:739–752. doi:10.1016/S0002-9440(10)65173-510487832
   PubMed Web of Science ®Google Scholar
• Sun T, Zhao N, Zhao XL, et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry. Hepatology. 2010;51:545–556. doi:10.1002/hep.2331119957372
   PubMed Web of Science ®Google Scholar
• Zhang D, Sun B, Zhao X, et al. Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple‐negative breast cancer. Mol Cancer. 2014;13:207. doi:10.1186/1476-4598-13-20725200065
   PubMed Web of Science ®Google Scholar
• Schnegg CI, Yang MH, Ghosh SK, et al. Induction of vasculogenic mimicry overrides VEGF‐A silencing and enriches stem‐like cancer cells in melanoma. Cancer Res. 2015;75:1682–1690. doi:10.1158/0008-5472.CAN-14-185525769726
   PubMed Web of Science ®Google Scholar
• Yang DH, Yoon JY, Lee SH, et al. Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta‐catenin and protein kinase Calpha. Circ Res. 2009;104:372–379. doi:10.1161/CIRCRESAHA.108.18540519096028
   PubMed Web of Science ®Google Scholar
• Qi L, Sun B, Liu Z, et al. Dickkopf‐1 inhibits epithelial‐mesenchymal transition of colon cancer cells and contributes to colon cancer suppression. Cancer Sci. 2012;103:828–835. doi:10.1111/j.1349-7006.2012.02222.x22321022
   PubMed Web of Science ®Google Scholar
• Yao L, Zhang D, Zhao X, et al. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. J Cell Mol Med. 2016;20(9):1673–1685. doi:10.1111/jcmm.1286227240974
   PubMed Web of Science ®Google Scholar
• Shen L, Wu X, Tan J, et al. Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer. Onco Targets Ther. 2017;10:3545–3556. doi:10.2147/OTT.S13416228790847
   PubMed Web of Science ®Google Scholar
• Qiao R, Zhong R, Chang Q, et al. Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases. Oncotarget. 2017;8(45):79469–79479. doi:10.18632/oncotarget.1844629108326
   PubMedGoogle Scholar
• Abdelaziz AO, Elbaz TM, Shousha HI, et al. Survival and prognostic factors for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Asian Pac J Cancer Prev. 2014;15:3915–3920. doi:10.7314/APJCP.2014.15.9.391524935574
   PubMedGoogle Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317–370.28620797
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Sangiovanni A, Colombo M. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2016;36(Suppl 1):124–129. doi:10.1111/liv.1302826725909
   PubMed Web of Science ®Google Scholar
• Aghoram R, Cai P, Dickinson JA. Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B. Cochrane Database Syst Rev. 2012;9:Cd002799.
   Google Scholar
• Llovet JM, Ducreux M, Lencioni R, et al. European association for the study of the liver, european organization for research and treatment of cancer, EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.22424438
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022. doi:10.1002/hep.2419921374666
   PubMed Web of Science ®Google Scholar
• Marrero JA, Feng Z, Wang Y, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009;137:110–118. doi:10.1053/j.gastro.2009.04.00519362088
   PubMed Web of Science ®Google Scholar
• Shen Q, Fan J, Yang XR, et al. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Lancet Oncol. 2012;13(8):817–826. doi:10.1016/S1470-2045(12)70233-422738799
   PubMed Web of Science ®Google Scholar
• Mazon M, Masi D, Carreau M. Modulating Dickkopf-1: a strategy to monitor or treat cancer? Cancers (Basel). 2016;8:62.
   PubMed Web of Science ®Google Scholar
• Choi SH, Kim H, Lee HG, et al. Dickkopf-1 induces angiogenesis via VEGF receptor 2 regulation independent of the Wnt signaling pathway. Oncotarget. 2017;8(35):58974–58984. doi:10.18632/oncotarget.1976928938611
   PubMedGoogle Scholar
• El-Serag HB, Marrero JA, Rudolph L, et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134:1752–1763. doi:10.1053/j.gastro.2008.02.09018471552
   PubMed Web of Science ®Google Scholar
• Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171. doi:10.1053/jhep.2002.3315611981766
   PubMed Web of Science ®Google Scholar
• Raoul JL, Sangro B, Forner A, et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev. 2011;37:212–220. doi:10.1016/j.ctrv.2010.07.00620724077
   PubMed Web of Science ®Google Scholar
• Wu X, Yang C, Yu H, Cao F, Shan Y, Zhao W. The predictive values of serum dickkopf-1 and circulating tumor cells in evaluating the efficacy of transcatheter arterial chemoembolization treatment on hepatocellular carcinoma. Medicine (Baltimore). 2019;98(30):e16579. doi:10.1097/MD.000000000001657931348291
   PubMed Web of Science ®Google Scholar
• Zhang HF, Wu C, Alshareef A, et al. The PI3K/AKT/c-MYC axis promotes the acquisition of cancer stem-like features in esophageal squamous cell carcinoma. Stem Cells. 2016;34:2040–2051. doi:10.1002/stem.239527144349
   PubMed Web of Science ®Google Scholar
• Agrawal N, Jiao Y, Bettegowda C, et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2012;2:899–905. doi:10.1158/2159-8290.CD-12-018922877736
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu JL, Wu Y, Zhang ZY, Wu R. Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. Tohoku J Exp Med. 2011;223:137–144. doi:10.1620/tjem.223.13721304218
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• Li S, Qin X, Liu B, et al. Dickkopf-1 is involved in invasive growth of esophageal cancer cells. J Mol Histol. 2011;42(6):491–498. doi:10.1007/s10735-011-9347-121909757
   PubMed Web of Science ®Google Scholar
• Begenik H, Kemik AS, Emre H, et al. The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma. Hum Exp Toxicol. 2014;33(8):785–788. doi:10.1177/096032711351053724220876
   PubMed Web of Science ®Google Scholar
• Makino T, Yamasaki M, Takemasa I, et al. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma. Ann Surg Oncol. 2009;16(7):2058–2064. doi:10.1245/s10434-009-0476-719408050
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Yada T, Yokoi C, Uemura N. The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc. 2013;2013:241320. doi:10.1155/2013/24132023533320
   PubMedGoogle Scholar
• Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24(18):2903–2909. doi:10.1200/JCO.2005.05.024516782930
   PubMed Web of Science ®Google Scholar
• Lee HS, Lee HE, Park DJ, Kim HH, Kim WH, Park KU. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer. Clin Chim Acta. 2012;413(21–22):1753–1760. doi:10.1016/j.cca.2012.07.00322796372
   PubMed Web of Science ®Google Scholar
• Zhuang GF, Tan Y, Zeng JT, et al. Expression of serum Dickkopf-1 in gastric cancer patients. Asian Pac J Trop Med. 2015;8(10):870–872. doi:10.1016/j.apjtm.2015.09.01626522305
   PubMed Web of Science ®Google Scholar
• Liu QR, Li YF, Deng ZQ, Cao JQ. Prognostic significance of Dickkopf-1 in gastric cancer survival: a meta-analysis. Genet Test Mol Biomarkers. 2016;20(4):170–175. doi:10.1089/gtmb.2015.015427023747
   PubMed Web of Science ®Google Scholar
• Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461–1473.27617575
   PubMed Web of Science ®Google Scholar
• Hong SA, Yoo SH, Lee HH, et al. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer. BMC Cancer. 2018;18(1):506. doi:10.1186/s12885-018-4420-829720122
   PubMed Web of Science ®Google Scholar
• Wang B, Liu J, Ma LN, et al. Chimeric 5/35 adenovirus-mediated Dickkopf-1 overexpression suppressed tumorigenicity of CD44+ gastric cancer cells via attenuating Wnt signaling. J Gastroenterol. 2013;48(7):798–808. doi:10.1007/s00535-012-0711-z23188090
   PubMed Web of Science ®Google Scholar
• Ferrarelli LK. Treating WNT-driven colorectal cancer. Science. 2017;356(6345):1346–1348. doi:10.1126/science.356.6345.1346-r
   PubMedGoogle Scholar
• Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27:2–12. doi:10.1186/s40880-015-0001-225717220
   PubMed Web of Science ®Google Scholar
• Galamb O, Kalmar A, Peterfia B, et al. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics. 2016;11(8):588–602. doi:10.1080/15592294.2016.119089427245242
   PubMed Web of Science ®Google Scholar
• Rennoll S, Yochum G. Regulation of MYC gene expression by aberrant Wnt/beta-catenin signaling in colorectal cancer. World J Biol Chem. 2015;6(4):290–300. doi:10.4331/wjbc.v6.i4.29026629312
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.28248415
   PubMed Web of Science ®Google Scholar
• Fan C, Lin Y, Mao Y, et al. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2. Oncotarget. 2016;7:21825–21839. doi:10.18632/oncotarget.798926968810
   PubMedGoogle Scholar
• Aguilera O, Fraga MF, Ballestar E, et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 2006;25(29):4116–4121. doi:10.1038/sj.onc.120943916491118
   PubMed Web of Science ®Google Scholar
• Rawson JB, Manno M, Mrkonjic M, et al. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis. 2011;32(5):741–747. doi:10.1093/carcin/bgr02021304055
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun B, Qi L, et al. Dickkopf-1 expression is down-regulated during the colorectal adenoma-carcinoma sequence and correlates with reduced microvessel density and VEGF expression. Histopathology. 2015;67(2):158–166. doi:10.1111/his.1247424916146
   PubMed Web of Science ®Google Scholar
• Jumpertz S, Hennes T, Asare Y, Schütz AK, Bernhagen J. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells. Cell Signal. 2017;34:38–46. doi:10.1016/j.cellsig.2017.02.01328229932
   PubMed Web of Science ®Google Scholar
• Wang W, He Y, Rui J, Xu MQ. miR-410 acts as an oncogene in colorectal cancer cells by targeting dickkopf-related protein 1 via the Wnt/β-catenin signaling pathway. Oncol Lett. 2019;17(1):807–814.30655833
   PubMed Web of Science ®Google Scholar
• Rui Y, Hu M, Wang P, et al. LncRNA HOTTIP mediated DKK1 downregulation confers metastasis and invasion in colorectal cancer cells. Histol Histopathol. 2019;34(6):619–630.30229808
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.2133226742998
   PubMed Web of Science ®Google Scholar
• Stotz M, Eisner F, Szkandera J, et al. Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series. J Clin Pathol. 2013;66(9):753–757. doi:10.1136/jclinpath-2012-20139423750038
   PubMed Web of Science ®Google Scholar
• Klein AP. Identifying people at a high risk of developing pancreatic cancer. Nat Rev Cancer. 2013;13(1):66–74. doi:10.1038/nrc342023222481
   PubMed Web of Science ®Google Scholar
• Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362(17):1605–1617. doi:10.1056/NEJMra090155720427809
   PubMed Web of Science ®Google Scholar
• Takahashi N, Fukushima T, Yorita K, Tanaka H, Chijiiwa K, Kataoka H. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth. Int J Cancer. 2010;126(7):1611–1620.19711349
   PubMed Web of Science ®Google Scholar
• Zhong Y, Wang Z, Fu B, et al. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS One. 2011;6(7):e22129.21811562
   PubMed Web of Science ®Google Scholar
• Han SX, Zhou X, Sui X, et al. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Oncotarget. 2015;6(23):19907–19917. doi:10.18632/oncotarget.452926101916
   PubMed Web of Science ®Google Scholar
• Liu DJ, Xie YX, Liu XX, et al. The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma. Cell Cycle. 2017;16(17):1622–1629. doi:10.1080/15384101.2017.135651028749252
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang Z, Tang Y, Chen X, Zhou J. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis. Oncol Lett. 2018;16(2):2453–2461.30013637
   PubMed Web of Science ®Google Scholar
• Pang EJ, Yang R, Fu XB, Liu YF. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol. 2015;36(4):2403–2407. doi:10.1007/s13277-014-2850-825481511
   PubMedGoogle Scholar
• Weng YC, Ma J, Zhang J, Wang JC. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway. Cancer Biol Ther. 2019;20(3):368–380. doi:10.1080/15384047.2018.152911030580676
   PubMed Web of Science ®Google Scholar
• Kimura H, Yamamoto H, Harada T, et al. CKAP4, a DKK1 receptor, is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy. Clin Cancer Res. 2019;25(6):1936–1947. doi:10.1158/1078-0432.CCR-18-212430610103
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394‐424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Small W, Bacon MA, Bajaj A, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404‐2412. doi:10.1002/cncr.30667
   Web of Science ®Google Scholar
• Kessler TA. Cervical cancer: prevention and early detection. Semin Oncol Nurs. 2017;33(2):172‐183. doi:10.1016/j.soncn.2017.02.005
   PubMed Web of Science ®Google Scholar
• Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer. 2017;123(12):2219–2229.28346680
   PubMed Web of Science ®Google Scholar
• Analytical BS, Barretos CH, Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–384.28112728
   PubMed Web of Science ®Google Scholar
• Lee J, Yoon YS, Chung JH. Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines. Gynecol Oncol. 2008;109(2):270‐274. doi:10.1016/j.ygyno.2008.01.034
   Web of Science ®Google Scholar
• Jiang T, Wang S, Huang L, Zhang S. Clinical significance of serum DKK-1 in patients with gynecological cancer. Int J Gynecol Cancer. 2009;19(7):1177‐1181. doi:10.1111/IGC.0b013e31819d8b2d
   Web of Science ®Google Scholar
• Jiang T, Huang L, Zhang S. DKK-1 in serum as a clinical and prognostic factor in patients with cervical cancer. Int J Biol Markers. 2013;28(2):221‐225. doi:10.5301/jbm.5000005
   Web of Science ®Google Scholar
• Chi C, Li M, Hou W, Chen Y, Zhang Y, Chen J. Long noncoding RNA SNHG7 activates Wnt/β-catenin signaling pathway in cervical cancer cells by epigenetically silencing DKK1. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2019.3004
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7‐30. doi:10.3322/caac.21442
   Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87‐108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Li X, Tang M, Zhu Q, Wang X, Lin Y, Wang X. The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration. Cell Oncol (Dordr). 2020;43(2):263‐277.
   Web of Science ®Google Scholar
• Vaughan S, Coward JI, Bast RC, et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer. 2011;11(10):719‐725. doi:10.1038/nrc3144
   PubMed Web of Science ®Google Scholar
• Garrido MP, Bruneau N, Vega M, Selman A, Tapia JC, Romero C. Follicle-stimulating hormone promotes nerve growth factor and vascular endothelial growth factor expression in epithelial ovarian cells. Histol Histopathol. 2020;18226.
   Web of Science ®Google Scholar
• Barbolina MV, Liu Y, Gurler H, et al. Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein. J Biol Chem. 2013;288(1):141–151. doi:10.1074/jbc.M112.43141123152495
   PubMed Web of Science ®Google Scholar
• Chen MW, Yang ST, Chien MH, et al. The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. Cancer Res. 2017;77(8):1955‐1967. doi:10.1158/0008-5472.CAN-16-1115
   Web of Science ®Google Scholar
• Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472–479. doi:10.1038/nature1275024153300
   PubMed Web of Science ®Google Scholar
• Scourzic L, Mouly E, Bernard OA. TET proteins and the control of cytosine demethylation in cancer. Genome Med. 2015;7(1):9.25632305
   PubMed Web of Science ®Google Scholar
• Kraus TF, Greiner A, Steinmaurer M, Dietinger V, Guibourt V, Kretzschmar HA. Genetic characterization of ten-eleven-translocation methylcytosine dioxygenase alterations in human glioma. J Cancer. 2015;6(9):832‐842. doi:10.7150/jca.12010
   Web of Science ®Google Scholar
• Rawłuszko-Wieczorek AA, Siera A, Horbacka K, Horst N, Krokowicz P, Jagodziński PP. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer. J Cancer Res Clin Oncol. 2015;141(8):1379‐1392. doi:10.1007/s00432-014-1901-2
   PubMed Web of Science ®Google Scholar
• Duan H, Yan Z, Chen W, et al. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Gynecol Oncol. 2017;147(2):408‐417. doi:10.1016/j.ygyno.2017.08.010
   PubMed Web of Science ®Google Scholar
• Chang W, Lim S, Song H, et al. Cordycepin inhibits vascular smooth muscle cell proliferation. Eur J Pharmacol. 2008;597(1–3):64–69. doi:10.1016/j.ejphar.2008.08.03018782572
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M. Antitumor effect of cordycepin (3ʹ-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res. 2006;26(1A):43‐47.
   Web of Science ®Google Scholar
• Shi P, Huang Z, Tan X, Chen G. Proteomic detection of changes in protein expression induced by cordycepin in human hepatocellular carcinoma BEL-7402 cells. Methods Find Exp Clin Pharmacol. 2008;30(5):347‐353. doi:10.1358/mf.2008.30.5.1186085
   PubMedGoogle Scholar
• Jang HJ, Yang KE, Hwang IH, et al. Cordycepin inhibits human ovarian cancer by inducing autophagy and apoptosis through Dickkopf-related protein 1/β-catenin signaling. Am J Transl Res. 2019;11(11):6890‐6906.
   PubMed Web of Science ®Google Scholar
• Betella I, Turbitt WJ, Szul T, et al. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer. Gynecol Oncol. 2020.
   Web of Science ®Google Scholar
• Saad ED, Katz A, Buyse M. Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials. J Clin Oncol. 2010;28(11):1958–1962. doi:10.1200/JCO.2009.25.541420194852
   PubMed Web of Science ®Google Scholar
• Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26(8):1355–1363. doi:10.1200/JCO.2007.13.343918227528
   PubMed Web of Science ®Google Scholar
• Karaman S, Detmar M. Mechanisms of lymphatic metastasis. J Clin Invest. 2014;124(3):922–928. doi:10.1172/JCI7160624590277
   PubMed Web of Science ®Google Scholar
• Voorzanger-Rousselot N, Journe F, Doriath V, Body JJ, Garnero P. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Calcif Tissue Int. 2009;84(5):348–354. doi:10.1007/s00223-009-9225-y19252761
   PubMed Web of Science ®Google Scholar
• Xu WH, Liu ZB, Yang C, Qin W, Shao ZM. Expression of dickkopf-1 and beta-catenin related to the prognosis of breast cancer patients with triple negative phenotype. PLoS One. 2012;7(5):e37624. doi:10.1371/journal.pone.003762422649545
   PubMed Web of Science ®Google Scholar
• Mariz K, Ingolf JB, Daniel H, Teresa NJ, Erich-Franz S. The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases. Clin Exp Metastasis. 2015;32(8):857–866. doi:10.1007/s10585-015-9750-126420587
   PubMed Web of Science ®Google Scholar
• Rachner TD, Göbel A, Browne A, Hötzel J, Rauner M, Hofbauer LC. P38 regulates the Wnt inhibitor Dickkopf-1 in breast cancer. Biochem Biophys Res Commun. 2015;466(4):728–732. doi:10.1016/j.bbrc.2015.09.10126407843
   PubMed Web of Science ®Google Scholar
• Rachner TD, Göbel A, Thiele S, et al. Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. Breast Cancer Res. 2014;16(1):R20.24528599
   PubMed Web of Science ®Google Scholar
• Göbel A, Browne AJ, Thiele S, Rauner M, Hofbauer LC, Rachner TD. Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins. Breast Cancer Res Treat. 2015;154(3):623‐631. doi:10.1007/s10549-015-3624-8
   PubMed Web of Science ®Google Scholar
• Li M, Cai H, Yang Y, et al. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway. Oncol Rep. 2016;36(2):936–944.27277008
   PubMed Web of Science ®Google Scholar
• Liu JT, Guo WB, Sun JY. Serum Dickkopf-1 acts as a new biomarker in human breast cancer. Minerva Med. 2017;108(4):334‐340.
   Web of Science ®Google Scholar
• Kasoha M, Bohle RM, Seibold A, Gerlinger C, Juhasz-Böss I, Solomayer EF. Dickkopf-1 (Dkk1) protein expression in breast cancer with special reference to bone metastases. Clin Exp Metastasis. 2018;35(8):763‐775. doi:10.1007/s10585-018-9937-3
   PubMed Web of Science ®Google Scholar
• Jaschke N, Kleymann A, Hofbauer LC, Göbel A, Rachner TD. Dorsomorphin: a novel inhibitor of Dickkopf-1 in breast cancer. Biochem Biophys Res Commun. 2020;524(2):360‐365. doi:10.1016/j.bbrc.2020.01.106
   PubMed Web of Science ®Google Scholar
• Li K, Lin T, Xue W, et al.. Current status of diagnosis and treatment of bladder cancer in China - analyses of Chinese Bladder Cancer Consortium database. Asian J Urol. 2015;2(2):63–69.29264122
   PubMedGoogle Scholar
• Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–475. doi:10.1016/j.eururo.2016.06.02027375033
   PubMed Web of Science ®Google Scholar
• Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15(1):25–41. doi:10.1038/nrc381725533674
   PubMed Web of Science ®Google Scholar
• Kaba M, Pirincci N, Benli E, et al. Dickkopf-1 levels in Turkish patients with bladder cancer and its association with clinicopathological features. Asian Pac J Cancer Prev. 2014;15(1):381‐384. doi:10.7314/APJCP.2014.15.1.381
   Google Scholar
• Sun DK, Wang L, Wang JM, Zhang P. Serum Dickkopf-1 levels as a clinical and prognostic factor in patients with bladder cancer. Genet Mol Res. 2015;14(4):18181–18187. doi:10.4238/2015.December.23.526782465
   PubMed Web of Science ®Google Scholar
• Gao RL, Chen XR, Li YN, et al. Upregulation of miR-543-3p promotes growth and stem cell-like phenotype in bladder cancer by activating the Wnt/β-catenin signaling pathway. Int J Clin Exp Pathol. 2017;10(9):9418–9426.31966814
   PubMed Web of Science ®Google Scholar
• Kagey MH, He X. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. Br J Pharmacol. 2017;174(24):4637–4650. doi:10.1111/bph.1389428574171
   PubMed Web of Science ®Google Scholar